State Of Wyoming Merus N.V. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $587 - $1,228	42 Added 32.06%	173 $4,000
Q1 2022 May 13, 2022	BUY	$23.58 - $30.91 $495 - $649	21 Added 19.09%	131 $3,000
Q4 2021 Feb 11, 2022	SELL	$20.0 - $32.29 $120 - $193	-6 Reduced 5.17%	110 $3,000
Q3 2021 Feb 11, 2022	SELL	$16.48 - $27.23 $906 - $1,497	-55 Reduced 32.16%	116 $3,000
Q2 2021 Feb 11, 2022	BUY	$20.0 - $25.48 $3,420 - $4,357	171 New	171 $4,000

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.